GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) » Definitions » Buildings And Improvements

Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Buildings And Improvements : ¥0.0 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Dizal (Jiangsu) Pharmaceutical Co Buildings And Improvements?

Dizal (Jiangsu) Pharmaceutical Co Buildings And Improvements Historical Data

The historical data trend for Dizal (Jiangsu) Pharmaceutical Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dizal (Jiangsu) Pharmaceutical Co Buildings And Improvements Chart

Dizal (Jiangsu) Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buildings And Improvements
Get a 7-Day Free Trial - - - - -

Dizal (Jiangsu) Pharmaceutical Co Quarterly Data
Dec18 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dizal (Jiangsu) Pharmaceutical Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

Dizal (Jiangsu) Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dizal (Jiangsu) Pharmaceutical Co Ltd (SHSE:688192) » Definitions » Buildings And Improvements
Comparable Companies
SZSE:000739 SZSE:300142 SHSE:600062 SZSE:000623 SHSE:600329 SZSE:002773 SZSE:300601 SHSE:603707 SZSE:300558 SHSE:600380 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
Jinghui East Road, Room 4105, Building E (Building 5), Huirong Business Plaza, Xinwu District, Jiangsu Province, Wuxi City, CHN, 201203
Website
http://www.dizalpharma.com
Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
Executives
Wu Qing Yi senior management
Lv Hong Bin senior management
Directors, senior managers
Directors, senior managers, core technical personn
Senior management, core technical personnel
Zheng Li Core technical personnel
Yang Zhen Fan Senior management, core technical personnel
Senior management, core technical personnel
Qiao Wei Jun Core technical personnel
Chen Kan Core technical personnel
Chen Su Qin Senior management, core technical personnel
Zhang Zhi Wei senior management
Senior management, core technical personnel
Senior management, core technical personnel

Dizal (Jiangsu) Pharmaceutical Co Headlines

No Headlines